Skip to main content

Loading market data...

ALGN

Align Technology, Inc.

NASDAQ • United states

$149.00

+$1.69

(+1.15%)

Source: Yahoo Finance · Quote time Oct 19, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Align Technology, Inc. (ALGN)

Unavailable

Quotes may be delayed

$10.58B

Market Cap

771,583

Volume

25.6

P/E Ratio

Unavailable

Div Yield

Align Technology, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, AZ
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

31 Aug 2026

Align Technology, Inc. reported A director or senior management change or compensation event

Align Technology, Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

12 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..

12 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..

5 Aug 2026

Align Technology, Inc. filed Form 10-Q

Align Technology, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.10B

Total assets (USD)$6.42B

Total liabilities (USD)$2.19B

Shareholders' equity (USD)$4.23B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.06B	$154.01M	$108.29M	$1.51	10-Q · 5 Aug 2026
Q1 2026	$1.04B	$141.96M	$112.77M	$1.57	10-Q · 6 May 2026
Q4 2025	$1.05B	$155.32M	$135.41M	Unavailable	10-K · 27 Feb 2026
Q3 2025	$995.69M	$96.30M	$56.75M	$0.78	10-Q · 5 Nov 2025
Q2 2025	$1.01B	$163.03M	$124.61M	$1.72	10-Q · 6 Aug 2025
Q1 2025	$979.26M	$131.10M	$93.23M	$1.27	10-Q · 8 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $196.80

32.1% upside potential

📈

Strong Buy

Unavailable

👍

Buy

7

⏸️

Hold

5

📉

Sell

1

13 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 12:48 UTC Targets range 155.00–240.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

20

May 2026

Vitalone Britt J.

Director

Option exercise

Unavailable per share

1,443 shares

20

May 2026

SIEGEL SUSAN E

Director

Option exercise

Unavailable per share

1,745 shares

20

May 2026

Saia Andrea Lynn

Director

Option exercise

Unavailable per share

1,745 shares

20

May 2026

Poul Mojdeh

Director

Option exercise

Unavailable per share

1,745 shares

20

May 2026

Myong Anne

Director

Option exercise

Unavailable per share

1,745 shares

20

May 2026

LARKIN C RAYMOND JR

Director

Option exercise

Unavailable per share

2,326 shares

20

May 2026

Dallas Kevin J

Director

Option exercise

Unavailable per share

1,745 shares

Top Shareholders

Vanguard Group Inc

8,179,779 shares

-1.468% change

12/31/2025

Blackrock, Inc.

4,419,366 shares

3.017% change

6/30/2026

Vanguard Capital Management Llc

4,401,313 shares

0.278% change

6/30/2026

Fmr Llc

4,060,032 shares

50.352% change

6/30/2026

Capital International Investors

4,045,561 shares

6.205% change

6/30/2026

Capital World Investors

3,422,385 shares

-15.959% change

6/30/2026

Goldman Sachs Group Inc

3,372,760 shares

87.767% change

6/30/2026

Vanguard Portfolio Management Llc

3,131,764 shares

-0.604% change

6/30/2026

State Street Corp

2,558,512 shares

1.679% change

6/30/2026

Geode Capital Management, Llc

2,245,315 shares

25.387% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 12:48 UTC· 1 day ago

Research coverage and investment tools

Align Technology, Inc. (ALGN) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Industrial Specialties). Its last price was US$149.00 on 19 Oct 2026. That is 27% of the way from its 52-week low of US$130.23 to its 52-week high of US$200.44. Its market capitalisation was US$10.58 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.06B	$154.01M	$108.29M	$1.51	71.7%	14.6%	$157.09M	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$1.04B	$141.96M	$112.77M	$1.57	70.8%	13.6%	$120.26M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$1.05B	$155.32M	$135.41M	Unavailable	65.3%	14.8%	$187.26M	10-K · 27 Feb 2026 (opens in a new tab)
Q3 2025	$995.69M	$96.30M	$56.75M	$0.78	64.2%	9.7%	$168.96M	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$1.01B	$163.03M	$124.61M	$1.72	69.9%	16.1%	$107.17M	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$979.26M	$131.10M	$93.23M	$1.27	69.5%	13.4%	$27.39M	10-Q · 8 May 2025 (opens in a new tab)

Cash and equivalents: $1.10B
Total assets: $6.42B
Total liabilities: $2.19B
Shareholders' equity: $4.23B

8-K · 31 Aug 2026 · Management change

Align Technology, Inc. reported A director or senior management change or compensation event (opens in a new tab)

Align Technology, Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.
SCHEDULE 13G/A · 12 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..
SCHEDULE 13G/A · 12 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..
SCHEDULE 13G · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Align Technology, Inc..
10-Q · 5 Aug 2026

Align Technology, Inc. filed Form 10-Q (opens in a new tab)

Align Technology, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Vitalone Britt J. Director	20 May 2026	Option exercise (M)	+1,443	—	Form 4 (opens in a new tab)
SIEGEL SUSAN E Director	20 May 2026	Option exercise (M)	+1,745	—	Form 4 (opens in a new tab)
Saia Andrea Lynn Director	20 May 2026	Option exercise (M)	+1,745	—	Form 4 (opens in a new tab)
Poul Mojdeh Director	20 May 2026	Option exercise (M)	+1,745	—	Form 4 (opens in a new tab)
Myong Anne Director	20 May 2026	Option exercise (M)	+1,745	—	Form 4 (opens in a new tab)
LARKIN C RAYMOND JR Director	20 May 2026	Option exercise (M)	+2,326	—	Form 4 (opens in a new tab)
Dallas Kevin J Director	20 May 2026	Option exercise (M)	+1,745	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	8,179,779	-1.468%
Blackrock, Inc.	6/30/2026	4,419,366	3.017%
Vanguard Capital Management Llc	6/30/2026	4,401,313	0.278%
Fmr Llc	6/30/2026	4,060,032	50.352%
Capital International Investors	6/30/2026	4,045,561	6.205%
Capital World Investors	6/30/2026	3,422,385	-15.959%
Goldman Sachs Group Inc	6/30/2026	3,372,760	87.767%
Vanguard Portfolio Management Llc	6/30/2026	3,131,764	-0.604%
State Street Corp	6/30/2026	2,558,512	1.679%
Geode Capital Management, Llc	6/30/2026	2,245,315	25.387%

Previous close: 147.31 USD
Day range: 145.40 – 149.85 USD
52-week range: 130.23 – 200.44 USD
Volume: 771,583
Market cap: $10.58B
Average volume: 883,533
P/E ratio: 25.6
EPS (FY 2025, diluted): 5.65 USD
Shares outstanding: 71.04M
Beta (5Y monthly): 1.75

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 19 Oct 2026, 20:00 UTC· 2 days ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:29 UTC· 41 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ALGN yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.